Want to see TSE:MJRX.X full AI Analyst Report?
Global Health Clinics (MJRX.X) AI Stock Analysis
Global Health Clinics
(CNQX:MJRX.X)
The overall score is weak, driven primarily by severe financial distress—sharp revenue decline, deep losses, negative equity, and sustained cash burn—indicating high failure risk and overshadowing other factors. Technical signals are mixed with only modest price strength against generally weak momentum, providing limited offset. Valuation remains unattractive given negative earnings and no dividend support, keeping the stock’s overall risk-reward profile poor.
Global Health Clinics (MJRX.X) vs. iShares MSCI Canada ETF (EWC)
- Market Cap
- CAD 417.43K
- Dividend Yield
- ―
- Average Volume (3M)
- 1,783
- Price to Earnings (P/E)
- -0.3
- Beta (1Y)
- -0.80
- Revenue Growth
- -78.90%
- EPS Growth
- -9.28%
- Country
- Canada
- Employees
- 8
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Drug Manufacturers - Specialty & Generic
Global Health Clinics Business Overview & Revenue Model
Company Description
Operating within the cannabis industry, Global Health Clinics Ltd. manages medical facilities that provide guidance to patients seeking to legally obtain and use marijuana. The company is also involved in creating psilocybin products designated for s...
Global Health Clinics Financial Statement Overview
Summary
Score is very low due to collapsing revenue, deep and growing net losses, negative equity, shrinking assets, rising debt, and persistently negative operating cash flow with no clear path to profitability.
Income Statement
12Very NegativeBalance Sheet
8Very NegativeCash Flow
15Very NegativeGlobal Health Clinics Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:MJRX.X, the sentiment is Positive. The current price of 0.40 is below the 20-day moving average (MA) of 0.40, above the 50-day MA of 0.30, and above the 200-day MA of 0.38, indicating a neutral trend. The MACD of 0.02 indicates Positive momentum. The RSI at 67.43 is Neutral, neither overbought nor oversold. The STOCH value of 0.00 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TSE:MJRX.X.
Global Health Clinics Peers Comparison
Overall Rating
TSE:GTII72Outperform
TSE:DHT.UN63Neutral
TSE:CURA56Neutral
TSE:VRNO51Neutral- TSE:MJRX.X42Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| TSE:GTII | 72Outperform | CAD 1.90B | 11.44 | 6.82% | ― | 3.81% | 344.13% |
| TSE:DHT.UN | 63Neutral | CAD 997.22M | -14.90 | -10.07% | 3.32% | 6.33% | -1216.48% |
| TSE:CURA | 56Neutral | CAD 3.12B | -60.28 | -4.47% | ― | 1.50% | 81.84% |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| TSE:VRNO | 51Neutral | CAD 2.17B | -1.66 | -28.93% | ― | 0.61% | 37.92% |
| TSE:MJRX.X | 42Neutral | CAD 417.43K | -0.28 | 28.54% | ― | -78.90% | -9.28% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| TSE:MJRX.X | Global Health Clinics Ltd. | 0.40 | -0.05 | -11.11% | |
| TSE:CURA | Curaleaf Holdings (Otc) | 11.77 | 0.49 | 4.34% | |
| TSE:GTII | Green Thumb Industries (OTC) | 8.70 | -0.80 | -8.42% | |
| TSE:VRNO | Verano Holdings Corp. | 6.32 | 0.00 | 0.00% | |
| TSE:DHT.UN | Dri Healthcare Plc Trust | 18.14 | 2.99 | 19.70% |
Global Health Clinics Corporate Events
Global Health Clinics Plans 9-for-1 Share Consolidation
PositiveGlobal Health Clinics Ltd. has announced plans to consolidate its share capital on a 9-for-1 basis, reducing its outstanding common shares from 9,392,113 to approximately 1,043,568, with fractional shares to be either rounded up or cancelled. The mov...
Global Health Clinics Announces 10-for-1 Share Consolidation to Reshape Capital Structure
NeutralGlobal Health Clinics Ltd. plans to consolidate its share capital on a 10-for-1 basis, reducing its outstanding common shares from 9,392,113 to approximately 1,043,568, with no fractional shares issued and small fractions cancelled or rounded up. The...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Aug 24, 2026